Envision Pharma Group is pleased to announce the appointment of Tom Langan as Chief Executive Officer (CEO), marking the start of an exciting new chapter in the company’s growth journey.
A seasoned healthcare leader with more than 30 years of experience, Tom brings deep expertise in leading technology and technology-enabled services businesses that serve life sciences clients globally. He assumes the role with immediate effect.
“It’s an incredible honor to join Envision at such a pivotal moment,” said Tom. “The company’s reputation as the leading provider of technology and technology-enabled services to healthcare companies has been built on over 20 years of deep understanding of the industry and the challenges it faces.
“Global healthcare is facing increasingly high costs and greater complexity than ever before, and I am proud to now lead Envision’s efforts to meet the critical need for advanced technology-enabled solutions that accelerate and derisk results for life sciences companies across the entire product life cycle.”
Tom joins Envision from Veradigm (formerly Allscripts: MDRX), where he most recently served as interim CEO. During his 7-year tenure, he held several senior roles, including President and Chief Commercial Officer (CCO), helping to drive integrated software, data, and analytics solutions across healthcare.
Prior to Veradigm, he served as CEO and CCO of Practice Fusion, a leading provider of cloud-based electronic health records, and as CCO at Symphony Health Solutions, a provider of healthcare data analytics and solutions.
His leadership style, described by colleagues as collaborative, progressive, client-focused, and growth-oriented, has consistently delivered measurable value for clients and teams alike.
“We were particularly impressed by Tom’s client-centric leadership and proven track record in technology innovation,” said Alistair Macdonald, Executive Chairman of Envision Pharma Group. “His experience aligns perfectly with Envision's mission to deliver cutting-edge solutions that address the complex challenges facing life sciences companies today.”
In his new role, Tom will lead Envision’s global operations and teams across the US, UK, and Asia-Pacific, supporting over 400 pharma and biotech clients, including all the top 20 pharmaceutical companies.
Alistair will continue as Executive Chairman and will work closely with Tom and the Executive Leadership Team to ensure Envision delivers the best technology and medical and strategic services to clients, while continuing to foster a strong culture and meaningful career opportunities for all employees. Please join us in welcoming Tom Langan to Envision Pharma Group.